$404.81+1.90 (+0.47%)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
Waters Corporation in the Healthcare sector is trading at $404.81 with a market capitalization of $40.5B. Wall Street consensus targets $440.65 (23 analysts), implying a +8.9% move over the next 12 months. The stock is currently near its 52-week high of $426.22, remaining 12.1% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | — | $1.27B↑ | $932.36M↑ | $799.89M↑ | $771.33M |
| Gross Profit | — | $588.00M↑ | $569.50M↑ | $472.08M↑ | $449.93M |
| Operating Income | — | -$47.00M↓ | $270.52M↑ | $192.11M↑ | $188.21M |
| Net Income | — | -$72.00M↓ | $225.21M↑ | $148.92M↑ | $147.11M |
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spect...

Waters stock has put in a strong multi year gain, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while the earnings multiple checks lean expensive. Over the past 3 years, Waters has returned about 53%, which puts more pressure on today’s entry price to be well supported by fundamentals. The company’s ability to keep converting its specialized analytical instruments and services into steady cash flow can...

Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted a 30 day share price return of 4.41% and a 90 day share price return of 13.19%. The 1 year total shareholder return of 38% and 3 year total shareholder return of 53% point to building momentum supported by upgraded guidance and recent leadership...

Waters Corporation recently announced that Senior Vice President of the Waters Analytical Sciences Division, Robert L. Carpio III, resigned in August 2026, with Tina Wu, previously head of the Materials Sciences Division and President, China, stepping into the role after more than two decades of global leadership experience at DuPont. Around the same time, Waters reported very large year-over-year revenue growth in the second quarter of 2026 and raised its full-year guidance, underlining the...

Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Although Waters Corporation has exceeded the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.
Academic risk and quality models computed from WAT's own filings and price history, not from analyst opinion.
Mixed: 4 of 9 fundamental-health tests pass, so profitability and balance-sheet trends disagree.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
Hidden Markov model fitted to two years of returns, separating bull, bear and sideways states by their own drift and volatility.
GARCH(1,1) 30-day annualised forecast, above the current 37.5% reading.
Fama-French 5-factor market beta. The five factors explain 17% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-09-08.